AVO warns of potential delays as supply chain issues continue

Advanced Oncotherapy CEO Nicolas Serandour

Advanced Oncotherapy (AVO) has warned that delivery of its next generation proton beam therapy LIGHT system with a 230MeV beam could be delayed until next year…

You must be a HM Subscriber to view this content.

Subscribe Now »